Literature DB >> 23161830

Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: a case report with brief review of immunomarkers.

Sinchita Roy Chowdhuri1, Patricia Fetsch, Jennifer Squires, Elise Kohn, Armando C Filie.   

Abstract

Distinguishing metastatic carcinoma cells from reactive mesothelial cells in effusion samples is often challenging based on morphology alone. Metastatic carcinoma cells in fluid samples may mimic reactive mesothelial cells due to overlapping cytological features. We report a case of a pleural effusion in a 51-year-old female patient with a medical history significant for bilateral ovarian tumors and peritoneal implants diagnosed as serous tumor of borderline malignant potential. The effusion was composed almost entirely of adenocarcinoma cells that morphologically mimicked reactive mesothelial cells. The diagnosis of metastatic adenocarcinoma was made after a wide immunostaining panel of antibodies. Recognizing metastatic adenocarcinoma cells in effusion samples can be challenging and an accurate diagnosis may have significant impact on clinical management as demonstrated by this case.
Copyright © 2012 Wiley Periodicals, Inc., a Wiley company.

Entities:  

Keywords:  adenocarcinoma cells; cytology; effusion; immunostaining; reactive mesothelial cells

Mesh:

Substances:

Year:  2012        PMID: 23161830      PMCID: PMC7682751          DOI: 10.1002/dc.22915

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  56 in total

1.  Calretinin: a novel immunocytochemical marker for mesothelioma.

Authors:  C Doglioni; A P Dei Tos; L Laurino; P Iuzzolino; C Chiarelli; M R Celio; G Viale
Journal:  Am J Surg Pathol       Date:  1996-09       Impact factor: 6.394

2.  Carcinoembryonic antigen (CEA) and gastrointestinal cancer associated antigen CA 19-9 in bronchioloalveolar carcinomas and pulmonary adenocarcinomas.

Authors:  L Heikkilä; R J Suomalainen; J Lindgren; H Jalanko; A Harjula; S Mattila
Journal:  Ann Chir Gynaecol       Date:  1986

3.  Comparison of three cytologic preparation methods and immunocytochemistries to distinguish adenocarcinoma cells from reactive mesothelial cells in serous effusion.

Authors:  Junko Ueda; Takako Iwata; Midori Ono; Mutsuo Takahashi
Journal:  Diagn Cytopathol       Date:  2006-01       Impact factor: 1.582

4.  Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma.

Authors:  N G Ordóñez
Journal:  Am J Surg Pathol       Date:  2000-04       Impact factor: 6.394

5.  Scoring system for differential diagnosis of malignant mesothelioma and reactive mesothelial cells on cytology specimens.

Authors:  Noriko Kimura; Kimiko Dota; Yoshikazu Araya; Takuzo Ishidate; Masanori Ishizaka
Journal:  Diagn Cytopathol       Date:  2009-12       Impact factor: 1.582

6.  Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma.

Authors:  Ben Davidson; Emilyn Alejandro; Vivi Ann Flørenes; Jeanne-Mette Goderstad; Björn Risberg; Gunnar B Kristensen; Claes G Trope; Elise C Kohn
Journal:  Cancer       Date:  2004-05-15       Impact factor: 6.860

7.  High sensitivity and specificity of CA 19-9 for pancreatic carcinoma in comparison to chronic pancreatitis. Serological and immunohistochemical findings.

Authors:  F Safi; R Roscher; R Bittner; B Schenkluhn; H P Dopfer; H G Beger
Journal:  Pancreas       Date:  1987       Impact factor: 3.327

Review 8.  Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: a review and update.

Authors:  Nelson G Ordóñez
Journal:  Adv Anat Pathol       Date:  2006-01       Impact factor: 3.875

Review 9.  Application of immunohistochemistry to the diagnosis of malignant mesothelioma.

Authors:  Alberto M Marchevsky
Journal:  Arch Pathol Lab Med       Date:  2008-03       Impact factor: 5.534

10.  Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions.

Authors:  Fabio Facchetti; Silvia Lonardi; Francesca Gentili; Luisa Bercich; Marcella Falchetti; Regina Tardanico; Carla Baronchelli; Laura Lucini; Alessandro Santin; Bruno Murer
Journal:  Virchows Arch       Date:  2007-07-03       Impact factor: 4.064

View more
  3 in total

1.  Abdominopelvic washings: A comprehensive review.

Authors:  Erika F Rodriguez; Sara E Monaco; Walid Khalbuss; R Marshall Austin; Liron Pantanowitz
Journal:  Cytojournal       Date:  2013-04-24       Impact factor: 2.091

2.  Diagnostic value of thyroid transcription factor-1 for pleural or other serous metastases of pulmonary adenocarcinoma: a meta-analysis.

Authors:  Yongchun Shen; Caishuang Pang; Konglong Shen; Yanqiu Wu; Diandian Li; Chun Wan; Zenglin Liao; Ting Yang; Lei Chen; Fuqiang Wen
Journal:  Sci Rep       Date:  2016-01-25       Impact factor: 4.379

3.  Staging laparoscopy and peritoneal cytology in patients with early stage gastric adenocarcinoma.

Authors:  Casey J Allen; Alisa N Blumenthaler; Prajnan Das; Bruce D Minsky; Mariela Blum; Sinchita Roy-Chowdhuri; Jaffer A Ajani; Naruhiko Ikoma; Paul F Mansfield; Brian D Badgwell
Journal:  World J Surg Oncol       Date:  2020-02-17       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.